These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4100023)

  • 1. Screening for angiotensin-induced hypertension.
    Lancet; 1971 Feb; 1(7693):277-8. PubMed ID: 4100023
    [No Abstract]   [Full Text] [Related]  

  • 2. Greene LL, Ferreira SH: Potential screening test for detection of overactivity of renin-angiotensin system.
    Krieger EM; Salgado HC; Assan CJ
    Lancet; 1971 Feb; 1(7693):269-71. PubMed ID: 4100019
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ; Camargo AC; Krieger EM; Stewart JM; Ferreira SH
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clarification of a hypertension].
    Cottier P
    Schweiz Med Wochenschr; 1970 Sep; 100(37):1557-63. PubMed ID: 4324235
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II. Vascular reactivity and humoral effects.
    Uza G
    Med Interne; 1976; 14(2):87-96. PubMed ID: 1024254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renin-angiotensin system in hypertension].
    Fyhrquist F
    Duodecim; 1974; 90(9):666-75. PubMed ID: 4371118
    [No Abstract]   [Full Text] [Related]  

  • 7. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive peptides.
    Sander GE; Huggins CG
    Annu Rev Pharmacol; 1972; 12():227-64. PubMed ID: 4339018
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides.
    Engel SL; Schaeffer TR; Gold BI; Rubin B
    Proc Soc Exp Biol Med; 1972 May; 140(1):240-4. PubMed ID: 4338183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renin-angiotensin system in the diagnosis of renovascular hypertension. Radioimmunoassay of angiotensin I and angiotensin II].
    Ripka O; Ort J; Linhartová J; Tvrzická E; Reinisová J
    Cas Lek Cesk; 1972 Jul; 111(35):818-20. PubMed ID: 4342732
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical study of the angiotensin perfusion test].
    Guédon J; Leroux-Robert C; Legrain M
    Pathol Biol; 1968 May; 16(9):559-63. PubMed ID: 4301234
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of angiotensin conversion in experimental renovascular hypertension.
    Miller ED; Samuels AI; Haber E; Barger AC
    Science; 1972 Sep; 177(4054):1108-9. PubMed ID: 4341125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renin-angiotensin and vasopressin in the pathogenesis of malignant hypertension].
    Möhring J
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():157-66. PubMed ID: 349924
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonists of angiotensin. Effect on the blood pressure of normal and hypertensive rats.
    Saint-Louis J; Regoli D
    Rev Can Biol; 1972 Dec; 31(4):241-51. PubMed ID: 4350595
    [No Abstract]   [Full Text] [Related]  

  • 17. The renin-angiotensin-aldosterone system (RAAS) clinical conditions with increased production of renin.
    Nahum LH
    Conn Med; 1965 Nov; 29(11):772-5 passim. PubMed ID: 4284416
    [No Abstract]   [Full Text] [Related]  

  • 18. Bradykinin potentiating factor.
    Greene LJ; Ferreira SH; Stewart JM
    Chest; 1971 May; 59():Suppl:9S-10S. PubMed ID: 4325034
    [No Abstract]   [Full Text] [Related]  

  • 19. Existence of a new vasoactive factor in experimental hypertension.
    Huang CT; Cardona R; Michelakis AM
    Am J Physiol; 1978 Jan; 234(1):E25-31. PubMed ID: 623244
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
    Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
    Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.